XGENE BIOTECHNOLOGY COMPANY LIMITED
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
Xgene’s key products are clinical-stage analgesic candidates, including oral dual‑mechanism conjugates and topical gels, designed to enhance efficacy and safety through multimodal mechanisms and high target specificity.
The content above was translated by Ai
Founded Year
2015
Unified Business No.
42836798
Status
Active
Number of Employees
0
Total Paid-in
Capital
100,000 (NT$)
Location of Company
Taiwan
, Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Xgene Pharmaceutical Inc. is an innovative biotech company focused on neurological disorders and pain management, using proprietary linker technology to develop dual‑acting prodrugs aimed at safer and more effective next‑generation analgesic therapies.
The content above was translated by Ai
